- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00233428
Study to Determine Racial and Gender Differences in Platelet Aggregation
Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation
Study Overview
Detailed Description
Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.
We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.
Study Type
Enrollment
Contacts and Locations
Study Locations
-
-
Texas
-
Lubbock, Texas, United States, 79430
- TTUHSC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Race of Caucasian, African American, or Hispanic
Exclusion Criteria:
- Chronic medical conditions
- Tobacco use
- Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Investigators
- Principal Investigator: Chanwit Roongsritong, MD, TTUHSC
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- L05-108
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Platelet Aggregation
-
Vanderbilt UniversityWithdrawnPlatelet AggregationUnited States
-
Edward R. Teitel, M.D.Completed
-
Ruhr University of BochumPfizerCompleted
-
Medisch Spectrum TwenteCompletedPlatelet Aggregation | Blood TransfusionNetherlands
-
AstraZenecaCompletedInhibition on Platelet AggregationUnited States
-
Ospedale Santa Croce-Carle CuneoUnknownPlatelet Aggregation Inhibitors
-
University of California, DavisCompletedVascular Function; Platelet AggregationUnited States
-
Aggredyne, Inc.Completed
-
Vanderbilt UniversityTerminatedPlatelet AggregationUnited States
-
National Council of Scientific and Technical Research...Merck Sharp & Dohme LLCCompletedInhibition of Platelet Aggregation by Incretins
Clinical Trials on Blood Draw
-
Abbott Point of CareNot yet recruitingPrecision of Potassium (K) Test in Capillary Whole Blood
-
University Hospital, Strasbourg, FranceNot yet recruitingKidney Transplantation | Humoral Rejection | Kidney Allograft Biopsy | Microvascular Inflammation
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Vanderbilt-Ingram Cancer CenterWren Laboratories LLCCompletedMelanomaUnited States
-
Turtle Health, Inc.Completed
-
National Heart Centre SingaporeDuke-NUS Graduate Medical SchoolRecruiting
-
Duke UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingHematologic MalignancyUnited States
-
University of BonnRecruitingSARS-CoV 2 | COVIDGermany
-
Joseph M. Still Research Foundation, Inc.RecruitingInflammatory Response | Deep Vein Thrombosis | Multi Organ Failure | Nosocomial InfectionUnited States